Literature DB >> 29134513

Current concepts and unmet needs in psoriatic arthritis.

Farrouq Mahmood1, Laura C Coates2, Philip S Helliwell3.   

Abstract

Psoriatic arthritis is a chronic inflammatory arthritis that is part of the spondyloarthropathy group of rheumatic diseases and has associated co-morbidities. It can present with various clinical manifestations making diagnosis and treatment challenging, resulting in significant disability and reduced quality of life for patients. Whilst there have been advances in understanding the pathogenic mechanisms of the disease which have resulted in targeted therapies, there is still the need for further studies as some patients fail or are intolerant of current therapies. Better identification of early disease and knowledge of prognostic markers would enable clinicians to initiate appropriate therapy with the expectation that early aggressive treatment will minimise joint damage progression. Improved knowledge of the condition would also enable clinicians to better tailor specific treatment strategies for each of the various clinical domains in psoriatic arthritis.

Entities:  

Keywords:  Biomarkers; CASPAR; Classification; Enthesitis; Treatment

Mesh:

Substances:

Year:  2017        PMID: 29134513     DOI: 10.1007/s10067-017-3908-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

Review 1.  The intestinal microbiome in spondyloarthritis.

Authors:  Tejpal Gill; Mark Asquith; James T Rosenbaum; Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

2.  Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab.

Authors:  Philip J Mease; Filip Van den Bosch; Joachim Sieper; Yinglin Xia; Aileen L Pangan; In-Ho Song
Journal:  J Rheumatol       Date:  2017-03-15       Impact factor: 4.666

Review 3.  Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.

Authors:  Siba P Raychaudhuri; Reason Wilken; Andrea C Sukhov; Smriti K Raychaudhuri; Emanual Maverakis
Journal:  J Autoimmun       Date:  2016-11-09       Impact factor: 7.094

4.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

5.  Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis.

Authors:  Muhammad Haroon; Phil Gallagher; Oliver FitzGerald
Journal:  Ann Rheum Dis       Date:  2014-02-13       Impact factor: 19.103

6.  Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).

Authors:  L C Coates; T Aslam; F Al Balushi; A D Burden; Esther Burden-Teh; E Burden-The; A R Caperon; R Cerio; C Chattopadhyay; H Chinoy; M J D Goodfield; L Kay; S Kelly; B W Kirkham; C R Lovell; H Marzo-Ortega; N McHugh; R Murphy; N J Reynolds; C H Smith; E J C Stewart; R B Warren; R Waxman; H E Wilson; P S Helliwell
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

Review 7.  Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.

Authors:  Antonio Marchesoni; Ennio Lubrano; Alberto Cauli; Massimo Ricci; Maria Manara
Journal:  J Rheumatol Suppl       Date:  2015-11

Review 8.  Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.

Authors:  Philip J Mease; April W Armstrong
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 9.  Recent advances in understanding and managing psoriatic arthritis.

Authors:  Dafna D Gladman
Journal:  F1000Res       Date:  2016-11-16

10.  Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.

Authors:  Arthur Kavanaugh; Philip J Mease; Juan J Gomez-Reino; Adewale O Adebajo; Jürgen Wollenhaupt; Dafna D Gladman; Eric Lespessailles; Stephen Hall; Marla Hochfeld; ChiaChi Hu; Douglas Hough; Randall M Stevens; Georg Schett
Journal:  Ann Rheum Dis       Date:  2014-03-04       Impact factor: 19.103

View more
  6 in total

Review 1.  Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Authors:  Francesco Caso; Antonio Del Puente; Francesca Oliviero; Rosario Peluso; Nicolò Girolimetto; Paolo Bottiglieri; Francesca Foglia; Carolina Benigno; Marco Tasso; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Clin Rheumatol       Date:  2018-01-08       Impact factor: 2.980

2.  Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype.

Authors:  Antonio Marchesoni
Journal:  Rheumatol Ther       Date:  2018-06-01

3.  Comprehensive analyses of long non-coding RNA expression profiles by RNA sequencing and exploration of their potency as biomarkers in psoriatic arthritis patients.

Authors:  Tao Yue; Mei Ji; Huanru Qu; Mengru Guo; Fengmin Bai; Zhanming Zhang; Weifeng Wang; Xuming Gong; Zhenghua Zhang
Journal:  BMC Immunol       Date:  2019-08-07       Impact factor: 3.615

4.  Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.

Authors:  Georgios Kokolakis; Kasper Vadstrup; Jes B Hansen; Jose Manuel Carrascosa
Journal:  Dermatology       Date:  2021-11-25       Impact factor: 5.197

5.  Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis.

Authors:  Kurt de Vlam; Philip J Mease; Andrew G Bushmakin; Roy Fleischmann; Alexis Ogdie; Valderilio F Azevedo; Joseph F Merola; John Woolcott; Joseph C Cappelleri; Lara Fallon; Peter C Taylor
Journal:  Rheumatol Ther       Date:  2022-09-08

6.  In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis.

Authors:  Garifallia Sakellariou; Silvana Quaglini; Serena Bugatti; Francesca Bobbio-Pallavicini; Vittorio Gabba; Carlomaurizio Montecucco
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.